Zobrazeno 1 - 10 of 1 299 pro vyhledávání: '"Waldeck K"'
1
Report
Human Parechovirus Associated Critical Illness in Neonates and Infants: Case Series and Review of Literature.
Autor: Daccache A; Pediatric Residency Program, University of Kansas School of Medicine-Wichita, Wichita, KS., Waldeck K; Marshall University Joan C. Edwards School of Medicine, Huntington, WV., Kilgore JT; Marshall University Joan C. Edwards School of Medicine, Huntington, WV., Lanata M; Marshall University Joan C. Edwards School of Medicine, Huntington, WV., Wittler RR; Pediatric Residency Program, University of Kansas School of Medicine-Wichita, Wichita, KS.; Wesley Children's Hospital, Wichita, KS., Agasthya N; Pediatric Residency Program, University of Kansas School of Medicine-Wichita, Wichita, KS.; Wesley Children's Hospital, Wichita, KS.
Publikováno v: Kansas journal of medicine [Kans J Med] 2023 Nov 30; Vol. 16, pp. 289-293. Date of Electronic Publication: 2023 Nov 30 (Print Publication: 2023).
Zobrazit plný text záznamu
2
Akademický článek
A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to 177 Lutetium-DOTA-octreotate radionuclide therapy.
Autor: Waldeck K; Models of Cancer Translational Research Centre, Research Division, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria, Australia, 3000.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia, 3010., Van Zuylekom J; Models of Cancer Translational Research Centre, Research Division, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria, Australia, 3000.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia, 3010., Cullinane C; Models of Cancer Translational Research Centre, Research Division, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria, Australia, 3000.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia, 3010., Gulati T; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia, 3010.; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria, Australia, 3000., Simpson KJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia, 3010.; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria, Australia, 3000.; Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, Victoria, Australia, 3010., Tothill RW; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia, 3010.; Department of Clinical Pathology and University of Melbourne Centre for Cancer Research, The University of Melbourne, Parkville, Victoria, Australia, 3010., Blyth B; Models of Cancer Translational Research Centre, Research Division, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria, Australia, 3000.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia, 3010., Hicks RJ; St Vincent's Hospital Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia, 3010.
Publikováno v: Theranostics [Theranostics] 2023 Aug 28; Vol. 13 (14), pp. 4745-4761. Date of Electronic Publication: 2023 Aug 28 (Print Publication: 2023).
Zobrazit plný text záznamu
3
Akademický článek
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival.
Autor: Gherardin NA; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, Victoria, Australia., Waldeck K; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Caneborg A; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Martelotto LG; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Balachander S; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Zethoven M; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Petrone PM; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Pattison A; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Quiñones-Parra SM; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia., Rossello F; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Posner A; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Wong A; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Weppler AM; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Hong A; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Jakrot V; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Raleigh J; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Hatzimihalis A; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Neeson PJ; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Deleso P; Radiation Oncology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Johnston M; Radiation Oncology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Liverpool Hospital, Sydney, New South Wales, Australia., Chua M; Radiation Oncology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Becker JC; German Cancer Consortium (DKTK), Translational Skin Cancer Research, University Medicine Essen, Essen and DKFZ, Heidelberg, Germany., Sandhu S; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., McArthur GA; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Gill AJ; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical, Research and The University of Sydney, Sydney, New South Wales, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.; New South Wales Health Pathology, Sydney, New South Wales, Australia., Hicks RJ; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Cancer Imaging Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Godfrey DI; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, Victoria, Australia., Tothill RW; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia. rtothill@unimelb.edu.au.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
Publikováno v: Cancer immunology research [Cancer Immunol Res] 2021 Jun; Vol. 9 (6), pp. 612-623. Date of Electronic Publication: 2021 Mar 05.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
RERE-AS1 enhances the effect of CDK4/6 inhibitor Ribociclib and suppresses malignant phenotype in breast cancer via MEK/ERK pathway.
Autor: Huang, Zhidong1 (AUTHOR), Lou, Kaixin1 (AUTHOR), Qi, Mengyang1 (AUTHOR), Wang, Jinhui1 (AUTHOR), Li, Linwei1 (AUTHOR), Sun, Bo1 (AUTHOR), Wang, Chen2 (AUTHOR), Zhou, Xirui2 (AUTHOR), Chen, Debo3,4 (AUTHOR) debochensr@fjmu.edu.cn, Liu, Hong1 (AUTHOR) liuhong_submit@tjmuch.com
Publikováno v: Journal of Translational Medicine. 11/21/2024, Vol. 22 Issue 1, p1-16. 16p.
Zobrazit plný text záznamu
6
Akademický článek
Predictive biomarkers in daily anatomic pathology – is there something ready for sarcomas? A review and insights for future directions.
Autor: Gallas, Luiza Fadul1 (AUTHOR) luiza.gallas@rededor.com.br, Pacca, André Morales1 (AUTHOR), de Andrade Natal, Rodrigo2,3 (AUTHOR)
Publikováno v: Surgical & Experimental Pathology. 11/20/2024, Vol. 7 Issue 1, p1-8. 8p.
Zobrazit plný text záznamu
7
Akademický článek
Risk factor analysis and prediction model construction for severe adenovirus pneumonia in children.
Autor: Liang, Yaowen1 (AUTHOR), Wu, Jinhuan2 (AUTHOR), Chen, Gang3 (AUTHOR), Du, Yuchen1 (AUTHOR), Yan, Yi4 (AUTHOR), Xie, Shuqin4 (AUTHOR), Qian, Wenxian1 (AUTHOR), Chen, Apeng4 (AUTHOR), Yi, Changhua1 (AUTHOR) chhuayi@sina.cn, Tian, Man4 (AUTHOR) tmsweet@163.com
Publikováno v: Italian Journal of Pediatrics. 10/9/2024, Vol. 50 Issue 1, p1-10. 10p.
Zobrazit plný text záznamu
8
Akademický článek
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer.
Autor: Noor A; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia., Van Zuylekom JK; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Rudd SE; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia., Waldeck K; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Roselt PD; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Haskali MB; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Wheatcroft MP; Telix Pharmaceuticals Limited, Suite 401, 55 Flemington Road, North Melbourne, Victoria 3051, Australia., Yan E; Telix Pharmaceuticals Limited, Suite 401, 55 Flemington Road, North Melbourne, Victoria 3051, Australia., Hicks RJ; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia., Cullinane C; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia., Donnelly PS; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2020 Sep 10; Vol. 63 (17), pp. 9258-9270. Date of Electronic Publication: 2020 Aug 13.
Zobrazit plný text záznamu
9
Akademický článek
Enhancing the anti-tumour activity of 177 Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP.
Autor: Cullinane C; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. carleen.cullinane@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. carleen.cullinane@petermac.org., Waldeck K; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Kirby L; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Rogers BE; Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, 63110, USA., Eu P; Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; School of Medicine, Deakin University, Geelong, Victoria, Australia., Tothill RW; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Parkville, Victoria, Australia., Hicks RJ; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Publikováno v: Scientific reports [Sci Rep] 2020 Jun 23; Vol. 10 (1), pp. 10196. Date of Electronic Publication: 2020 Jun 23.
Zobrazit plný text záznamu
10
Akademický článek
Bioprotective Respirator Assembled by Defective Carbon Nitride for Long‐Term Light Triggered Health Protection.
Autor: Zeng, Zhenxing1,2, Zhang, Qi1,2, Ye, Fei3, Dang, Xueming4, Jiang, Xin5, Lv, Guochun1 14813@sicau.edu.cn, Wang, Xiaojing1,2, Peng, Hong1, Fang, Dexin1, Xiao, Hong1, Zhang, Yanzong1, Wu, Ganxue1, Mao, Jie6 jiemao@rcees.ac.cn, Ahmad, Munir7, Deng, Shihuai1,2 10113@sicau.edu.cn
Publikováno v: Advanced Science. 8/21/2024, Vol. 11 Issue 31, p1-10. 10p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje